Literature DB >> 30873584

Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma.

Greg Hapgood1, Susana Ben-Neriah2, Anja Mottok2, Derrick G Lee3, Kridel Robert2,4, Diego Villa1, Laurie H Sehn1, Joseph M Connors1, Randy D Gascoyne5, Andrew L Feldman6, Pedro Farinha5, Christian Steidl2, David W Scott1, Graham W Slack5, Kerry J Savage1.   

Abstract

Entities:  

Keywords:  DUSP22-rearranged ALK-negative ALCL; prognosis

Mesh:

Substances:

Year:  2019        PMID: 30873584     DOI: 10.1111/bjh.15860

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  12 in total

1.  Reply to "PD-L1 expression in anaplastic large cell lymphoma".

Authors:  Jie Xu; Shaoying Li; L Jeffrey Medeiros
Journal:  Mod Pathol       Date:  2020-03-18       Impact factor: 7.842

Review 2.  The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.

Authors:  Rita Alaggio; Catalina Amador; Ioannis Anagnostopoulos; Ayoma D Attygalle; Iguaracyra Barreto de Oliveira Araujo; Emilio Berti; Govind Bhagat; Anita Maria Borges; Daniel Boyer; Mariarita Calaminici; Amy Chadburn; John K C Chan; Wah Cheuk; Wee-Joo Chng; John K Choi; Shih-Sung Chuang; Sarah E Coupland; Magdalena Czader; Sandeep S Dave; Daphne de Jong; Ming-Qing Du; Kojo S Elenitoba-Johnson; Judith Ferry; Julia Geyer; Dita Gratzinger; Joan Guitart; Sumeet Gujral; Marian Harris; Christine J Harrison; Sylvia Hartmann; Andreas Hochhaus; Patty M Jansen; Kennosuke Karube; Werner Kempf; Joseph Khoury; Hiroshi Kimura; Wolfram Klapper; Alexandra E Kovach; Shaji Kumar; Alexander J Lazar; Stefano Lazzi; Lorenzo Leoncini; Nelson Leung; Vasiliki Leventaki; Xiao-Qiu Li; Megan S Lim; Wei-Ping Liu; Abner Louissaint; Andrea Marcogliese; L Jeffrey Medeiros; Michael Michal; Roberto N Miranda; Christina Mitteldorf; Santiago Montes-Moreno; William Morice; Valentina Nardi; Kikkeri N Naresh; Yasodha Natkunam; Siok-Bian Ng; Ilske Oschlies; German Ott; Marie Parrens; Melissa Pulitzer; S Vincent Rajkumar; Andrew C Rawstron; Karen Rech; Andreas Rosenwald; Jonathan Said; Clémentine Sarkozy; Shahin Sayed; Caner Saygin; Anna Schuh; William Sewell; Reiner Siebert; Aliyah R Sohani; Reuben Tooze; Alexandra Traverse-Glehen; Francisco Vega; Beatrice Vergier; Ashutosh D Wechalekar; Brent Wood; Luc Xerri; Wenbin Xiao
Journal:  Leukemia       Date:  2022-06-22       Impact factor: 12.883

Review 3.  Classification and diagnostic evaluation of nodal T- and NK-cell lymphomas.

Authors:  Andrew L Feldman; Camille Laurent; Marina Narbaitz; Shigeo Nakamura; Wing C Chan; Laurence de Leval; Philippe Gaulard
Journal:  Virchows Arch       Date:  2022-10-10       Impact factor: 4.535

4.  Super-enhancer-based identification of a BATF3/IL-2R-module reveals vulnerabilities in anaplastic large cell lymphoma.

Authors:  Stephan Mathas; Lukas Kenner; Olaf Merkel; Huan-Chang Liang; Mariantonia Costanza; Nicole Prutsch; Mark W Zimmerman; Elisabeth Gurnhofer; Ivonne A Montes-Mojarro; Brian J Abraham; Nina Prokoph; Stefan Stoiber; Simone Tangermann; Cosimo Lobello; Jan Oppelt; Ioannis Anagnostopoulos; Thomas Hielscher; Shahid Pervez; Wolfram Klapper; Francesca Zammarchi; Daniel-Adriano Silva; K Christopher Garcia; David Baker; Martin Janz; Nikolai Schleussner; Falko Fend; Šárka Pospíšilová; Andrea Janiková; Jacqueline Wallwitz; Dagmar Stoiber; Ingrid Simonitsch-Klupp; Lorenzo Cerroni; Stefano Pileri; Laurence de Leval; David Sibon; Virginie Fataccioli; Philippe Gaulard; Chalid Assaf; Fabian Knörr; Christine Damm-Welk; Wilhelm Woessmann; Suzanne D Turner; A Thomas Look
Journal:  Nat Commun       Date:  2021-09-22       Impact factor: 17.694

Review 5.  Genetic profiling and biomarkers in peripheral T-cell lymphomas: current role in the diagnostic work-up.

Authors:  Francisco Vega; Catalina Amador; Amy Chadburn; Eric D Hsi; Graham Slack; L Jeffrey Medeiros; Andrew L Feldman
Journal:  Mod Pathol       Date:  2021-09-28       Impact factor: 7.842

6.  Molecular profiling of Chinese systemic anaplastic large cell lymphoma patients: novel evidence of genetic heterogeneity.

Authors:  Li-Hua Zhong; Zhi-Da Wu; Jian-Chao Wang; Zai-Zeng Wu; Fang-Fang Chen; Wei-Feng Zhu; Yan-Ping Chen; Gang Chen
Journal:  Ann Transl Med       Date:  2021-01

7.  Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement.

Authors:  Shino Magaki; Radha Satyadev; Zesheng Chen; Kathryn S Yung; Harry V Vinters; Marsha C Kinney; Jonathan W Said
Journal:  Brain Tumor Pathol       Date:  2021-11-18       Impact factor: 3.298

8.  PD-L1 expression in anaplastic large cell lymphoma.

Authors:  Jianping Kong; Surendra Dasari; Andrew L Feldman
Journal:  Mod Pathol       Date:  2020-01-02       Impact factor: 7.842

Review 9.  How to Sequence Therapies in Peripheral T Cell Lymphoma.

Authors:  Kitsada Wudhikarn; N Nora Bennani
Journal:  Curr Treat Options Oncol       Date:  2021-07-02

Review 10.  Treatment approaches in relapsed or refractory peripheral T-cell lymphomas.

Authors:  Cheryl Foster; John Kuruvilla
Journal:  F1000Res       Date:  2020-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.